MyAverix Finance
SHG · Healthcare
Hangzhou Biotest Biotech Co Ltd (688767)
Biotechnology
Hangzhou Biotest Biotech Co Ltd (688767) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $4.80B, P/E ratio is 47.28, net margin is 10.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688767
Hangzhou Biotest Biotech Co Ltd (688767) — FAQ
What is Hangzhou Biotest Biotech Co Ltd's market cap?
Hangzhou Biotest Biotech Co Ltd (688767) has a reported market cap of $4.80B (data as of 2026-03-29).
What is 688767's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou Biotest Biotech Co Ltd (688767) is 47.28 (data as of 2026-03-29).
Does Hangzhou Biotest Biotech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou Biotest Biotech Co Ltd (688767). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou Biotest Biotech Co Ltd in?
Hangzhou Biotest Biotech Co Ltd (688767) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688767 listed on?
688767 is listed on SHG.
What is Hangzhou Biotest Biotech Co Ltd's net margin?
Hangzhou Biotest Biotech Co Ltd (688767) reports a net margin of 10.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.